Current knowledge and future research directions in treatment-related second primary malignancies
Currently, 17–19% of all new primary malignancies occur in survivors of cancer, causing substantial morbidity and mortality. Research has shown that cancer treatments are important contributors to second malignant neoplasm (SMN) risk. In this paper we summarise current knowledge with regard to treat...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2014-06-01
|
| Series: | EJC Supplements |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1359634914000032 |